Lung Nodule and Pulmonary Fibrosis at First Evaluation in Smoker Undergoing a Smoking Cessation Program
DOI:
https://doi.org/10.12974/2312-5470.2022.08.03Keywords:
Smoking, Pulmonary fibrosis, Lung noduleAbstract
Smoking is the most significant avoidable risk factor. Responsible for a wide range of diseases such as cardiovascular diseases and acute or chronic respiratory diseases.
It is frequently associated with interstitial pulmonary diseases and notably, it can be a cause of idiopathic pulmonary fibrosis.
In this report, lung nodules and idiopathic pulmonary fibrosis were presented in a heavy smoker.
References
Unverdorben M, Mostert A, Munjal S, van der Bijl A, Potgieter L, Venter C, et al. Acute effects of cigarette smoking on pulmonary function. Regul Toxicol Pharmacol 2010: RTP. 2010; 57(2-3): 241-6. https://doi.org/10.1016/j.yrtph.2009.12.013
Tonini G, D'Onofrio L, Dell'Aquila E, Pezzuto A. New molecular insights in tobacco-induced lung cancer. Future Oncol. 2013 May; 9(5): 649-55. https://doi.org/10.2217/fon.13.32
Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997 Jan; 155(1): 242-8. https://doi.org/10.1164/ajrccm.155.1.9001319
Maci E, Comito F, Frezza AM, Tonini G, Pezzuto A. Lung nodule and functional changes in smokers after smoking cessation short-term treatment. Cancer Invest. 2014 Oct; 32(8): 388-93. doi: 10.3109/07357907.2014.919308. Epub 2014 Jun 18. PMID: 24941266. https://doi.org/10.3109/07357907.2014.919308
Kishaba T, Nagano H, Nei Y, Yamashiro S. Clinical characteristics of idiopathic pulmonary fibrosis patients according to their smoking status. J Thorac Dis. 2016 Jun; 8(6): 1112-1120. https://doi.org/10.21037/jtd.2016.03.89
Lee CT, Feary J, Johannson KA. Env ironmental and occupational exposures in interstitial lung disease. Curr Opin Pulm Med. 2022 Sep 1; 28(5): 414-420. https://doi.org/10.1097/MCP.0000000000000894
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000 Feb; 161(2pt): 646-664. https://doi.org/10.1164/ajrccm.161.2.ats3-00
van Riel SJ, Sánchez CI, Bankier AA, Naidich DP, Verschakelen J, Scholten ET, de Jong PA, Jacobs C, van Rikxoort E, Peters-Bax L, Snoeren M, Prokop M, van Ginneken B, Schaefer-Prokop C. Observer Variability for Classification of Pulmonary Nodules on Low-Dose CT Images and Its Effect on Nodule Management. Radiology. 2015 Dec; 277(3): 863-71. https://doi.org/10.1148/radiol.2015142700
Naidich DP, Bankier AA, MacMahon H, Schaefer-Prokop CM, Pistolesi M, Goo JM, Macchiarini P, Crapo JD, Herold CJ, Austin JH, Travis WD. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology. 2013 Jan; 266(1): 304-17. https://doi.org/10.1148/radiol.12120628
Pezzuto A, Carico E. Effectiveness of smoking cessation in smokers with COPD and nocturnal oxygen desaturation: Functional analysis. Clin Respir J. 2020; 14(1): 29-34. https://doi.org/10.1111/crj.13096
D'Ascanio M, Viccaro F, Calabrò N, Guerrieri G, Salvucci C, Pizzirusso D, Mancini R, De Vitis C, Pezzuto A, Ricci A. Assessing Static Lung Hyperinflation by Whole-Body Plethysmography, Helium Dilution, and Impulse Oscillometry System (IOS) in Patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020 Oct 21; 15: 2583-2589. https://doi.org/10.2147/COPD.S264261
